Literature DB >> 15916851

Association between platelet activation and fibrinolysis in acute stroke patients.

Jian Wang1, Jianzhang Li, Qiqiang Liu.   

Abstract

We aimed to evaluate platelet activation and fibrinolyis in acute atherosclerotic ischemic stroke patients to clarify the relationship between them. Plasma P-selectin antigen, tissue plasminogen activator (tPA) antigen and activity, and plasminogen activator inhibitor-1 (PAI-1) activity were determined in 60 acute atherosclerotic stroke patients and matched control subjects. All patients were examined within 72 h after stroke onset. The levels of P-selectin, tPA antigen, and PAI-1 activity were all significantly higher in stroke patients compared with controls (all p < 0.0001); the level of tPA activity was significantly lower in patients than that in controls (p < 0.0001). These markers did not change much at different time points within 72 h. In stroke group, P-selectin concentration was highly correlated to PAI-1 activity (r = 0.8433, p < 0.001), but not to tPA antigen (r = -0.1752, p > 0.05), and tPA activity (r = 0.2465, p>0.05), which was further confirmed in the multiple linear regression analysis (F = 47.052, p < 0.0001). Our results indicate increased platelet activation and decreased fibrinolysis in patients with acute atherosclerotic ischemic stroke. Increased platelet activation may be correlated with decreased fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15916851     DOI: 10.1016/j.neulet.2005.04.090

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  Plasma fibrinolysis inhibitor levels in acute stroke patients with thrombolysis failure.

Authors:  Seo Hyun Kim; Sang Won Han; Eun Hee Kim; Dong Joon Kim; Kyung Yul Lee; Dong Ik Kim; Ji Hoe Heo
Journal:  J Clin Neurol       Date:  2005-10-20       Impact factor: 3.077

2.  CD40 ligand as a potential biomarker for atherosclerotic instability.

Authors:  Jing-Hua Wang; Yong-Wei Zhang; Ping Zhang; Ben-Qiang Deng; Suju Ding; Zhong-Kui Wang; Tao Wu; Jian Wang
Journal:  Neurol Res       Date:  2013-03-15       Impact factor: 2.448

3.  Tissue plasminogen activator; identifying major barriers related to intravenous injection in ischemic acute cerebral infraction.

Authors:  Fariborz Khorvash; Fatemeh Heidary; Mohammad Saadatnia; Ahmad Chitsaz; Zahra Tolou-Ghamari
Journal:  J Res Med Sci       Date:  2017-02-16       Impact factor: 1.852

Review 4.  Proteolysis is the most fundamental property of malignancy and its inhibition may be used therapeutically (Review).

Authors:  Marzena Wyganowska-Świątkowska; Mateusz Tarnowski; Daniel Murtagh; Ewa Skrzypczak-Jankun; Jerzy Jankun
Journal:  Int J Mol Med       Date:  2018-11-07       Impact factor: 4.101

5.  Behçet's disease: new insight into the relationship between procoagulant state, endothelial activation/damage and disease activity.

Authors:  Ihosvany Fernández-Bello; Francisco J López-Longo; Elena G Arias-Salgado; Víctor Jiménez-Yuste; Nora V Butta
Journal:  Orphanet J Rare Dis       Date:  2013-05-27       Impact factor: 4.123

Review 6.  Search for Reliable Circulating Biomarkers to Predict Carotid Plaque Vulnerability.

Authors:  Núria Puig; Elena Jiménez-Xarrié; Pol Camps-Renom; Sonia Benitez
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.